FILTER
LATEST INTERVIEWS
Roberto Xavier
EXECUTIVE DIRECTOR, ADIMB
"Brazil has the geology to be a leader in the future of critical minerals, but we do have some hurdles to overcome."
Jeff Quartermaine
MANAGING DIRECTOR & CEO, PERSEUS MINING
"Operationally, throughout the year we have systematically been at the top end of our production guidance and below the bottom end of our cost guidance."
Christine Burow
CHIEF MARKETING OFFICER, TORNGAT METALS
"We believe in the goal of growing a rare earth industry in Canada, which means multiple projects need to get into production here within the next few years."
Martina Azcurra
EXECUTIVE MANAGER, CHEMICALS, YPF QUÍMICA
"We want to double crude oil production in five years and increase gas production by 1.5 times."
Carlos Henrique Lemos Dantas
CEO, POCHTECA COREMAL BRAZIL
"Complex tax and labour legislation, together with Brazil´s large geographic span make the distribution space a very special one when compared to other markets."
Alfonso González
SALES DIRECTOR ENERGY, MINING AND INDUSTRY, HILTI
"We have demonstrated that even heavy applications like concrete demolition and cutting can be powered by batteries."
Gonzalo Silva
REGIONAL MANAGER FLOW CONTROL BUSINESS LINE, VALMET
"After acquiring the Flowrox portfolio, we expect to double our revenues from the mining industry by 2023 and boost our flow control line with local stock."
N’guessan Nestor Houssou
MANAGING DIRECTOR, GEOREC SARL
"GEOREC is an innovative, fast-growing company, and a benchmark consultancy in West Africa. We are expanding into Central Africa with the opening of an office in CAR."
Mostafa Talaat
CEO, ANKH RESOURCES
"Ankh Resources is a junior exploration company that specializes in gold exploration in the Arab Nubian Shield (ANS)."
Joe Walsh
MANAGING DIRECTOR, LEPIDICO
"The company is exceptionally proud that we have an all-Namibian leadership team within Namibia."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
